RecruitingNCT04837352

Therapeutic Adherence of Multiple Sclerosis Patients

Obstacles and Levers of the Therapeutic Adherence of Multiple Sclerosis Patients


Sponsor

Lille Catholic University

Enrollment

153 participants

Start Date

Jan 18, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to assess the role of sociocognitive and interpersonal factors in the therapeutic adherence of multiple sclerosis patients. This study will provide a better understanding of the socio-psychological issues associated with different types of non-adherence to treatment, and identify the risk factors and vulnerability of each patient.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how well people with multiple sclerosis (MS) stick to their prescribed medications over time. Researchers want to understand what factors affect whether patients take their treatments as directed, in order to improve long-term care. **You may be eligible if:** - You have been diagnosed with multiple sclerosis - You are currently on or starting a self-managed MS treatment (not one given in hospital) - You are 18 years of age or older - You have provided informed consent **You may NOT be eligible if:** - You have severe cognitive impairment - You have another serious neurological condition or a major chronic illness such as cancer - You are under a legal guardianship or protection measure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStudy of the role of sociocognitive factors

Questionnaires


Locations(4)

CHRU DE Bordeaux

Bordeaux, France

Hôpital Saint-Vincent de Paul

Lille, France

Hôpital Saint-Philibert

Lomme, France

CHRU de Strasbourg

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04837352


Related Trials